SB
Syntis Bio at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Syntis Bio brings 2 presentations to ObesityWeek 2026 in National Harbor. Its sessions report early clinical studies of SYNT-101. They cover safety, tolerability, pharmacokinetics and pharmacodynamics in a single ascending dose study in adults and a 28-day study in adults with obesity.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
SB Syntis Bio Boston, MA | |
Develops a once-daily oral pill that temporarily coats the upper small intestine to mimic the metabolic effects of gastric bypass. | Poster Mon Nov 16 2:30pm–3:30pm Single Ascending Dose Study to Evaluate the Safety, Tolerability, PK, and PD of SYNT-101 in Adults Pediatric and adolescent obesityObesity pharmacotherapy and drug development Poster Mon Nov 16 2:30pm–3:30pm 28-Day Study to Evaluate the Safety, Tolerability, PK, and PD of SYNT-101 in Adults with Obesity Pediatric and adolescent obesityObesity pharmacotherapy and drug development |
Find decision makers at Syntis Bio
Tell us what you sell and we’ll find the people at Syntis Bio most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction